138 related articles for article (PubMed ID: 36789877)
21. Targeting TPX2 suppresses proliferation and promotes apoptosis via repression of the PI3k/AKT/P21 signaling pathway and activation of p53 pathway in breast cancer.
Chen M; Zhang H; Zhang G; Zhong A; Ma Q; Kai J; Tong Y; Xie S; Wang Y; Zheng H; Guo L; Lu R
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):74-82. PubMed ID: 30454896
[TBL] [Abstract][Full Text] [Related]
22. TPX2 expression is associated with poor survival in gastric cancer.
Tomii C; Inokuchi M; Takagi Y; Ishikawa T; Otsuki S; Uetake H; Kojima K; Kawano T
World J Surg Oncol; 2017 Jan; 15(1):14. PubMed ID: 28069036
[TBL] [Abstract][Full Text] [Related]
23. Targeting of TRX2 by miR-330-3p in melanoma inhibits proliferation.
Yao Y; Zuo J; Wei Y
Biomed Pharmacother; 2018 Nov; 107():1020-1029. PubMed ID: 30257313
[TBL] [Abstract][Full Text] [Related]
24. TPX2 as a prognostic indicator and potential therapeutic target in clear cell renal cell carcinoma.
Glaser ZA; Love HD; Guo S; Gellert L; Chang SS; Herrell SD; Barocas DA; Penson DF; Cookson MS; Clark PE
Urol Oncol; 2017 May; 35(5):286-293. PubMed ID: 28108243
[TBL] [Abstract][Full Text] [Related]
25. TPX2 silencing mediated by joint action of microvesicles and ultrasonic radiation inhibits the migration and invasion of SKOV3 cells.
Huang D; Chen J; Yang C; Wang M
Mol Med Rep; 2018 Jun; 17(6):7627-7635. PubMed ID: 29620263
[TBL] [Abstract][Full Text] [Related]
26. Tpx2 controls spindle integrity, genome stability, and tumor development.
Aguirre-Portolés C; Bird AW; Hyman A; Cañamero M; Pérez de Castro I; Malumbres M
Cancer Res; 2012 Mar; 72(6):1518-28. PubMed ID: 22266221
[TBL] [Abstract][Full Text] [Related]
27. TPX2 Level Correlates with Hepatocellular Carcinoma Cell Proliferation, Apoptosis, and EMT.
Liang B; Jia C; Huang Y; He H; Li J; Liao H; Liu X; Liu X; Bai X; Yang D
Dig Dis Sci; 2015 Aug; 60(8):2360-72. PubMed ID: 26025609
[TBL] [Abstract][Full Text] [Related]
28. TPX2 is a prognostic marker and contributes to growth and metastasis of human hepatocellular carcinoma.
Huang Y; Guo W; Kan H
Int J Mol Sci; 2014 Oct; 15(10):18148-61. PubMed ID: 25302620
[TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4.
Yang C; Shen S; Zheng X; Ye K; Ge H; Sun Y; Lu Y
FASEB J; 2020 May; 34(5):6055-6069. PubMed ID: 32239565
[TBL] [Abstract][Full Text] [Related]
30. TPX2 expression is associated with cell proliferation and patient outcome in esophageal squamous cell carcinoma.
Hsu PK; Chen HY; Yeh YC; Yen CC; Wu YC; Hsu CP; Hsu WH; Chou TY
J Gastroenterol; 2014 Aug; 49(8):1231-40. PubMed ID: 23963785
[TBL] [Abstract][Full Text] [Related]
31. The critical role of dysregulated Hh-FOXM1-TPX2 signaling in human hepatocellular carcinoma cell proliferation.
Wang Y; Wang H; Yan Z; Li G; Hu G; Zhang H; Huang D; Wang Y; Zhang X; Yan Y; Lu Q; Cheng M; Luo S
Cell Commun Signal; 2020 Jul; 18(1):116. PubMed ID: 32723329
[TBL] [Abstract][Full Text] [Related]
32. NUF2 promotes tumorigenesis by interacting with HNRNPA2B1 via PI3K/AKT/mTOR pathway in ovarian cancer.
Ren M; Zhao H; Gao Y; Chen Q; Zhao X; Yue W
J Ovarian Res; 2023 Jan; 16(1):17. PubMed ID: 36670423
[TBL] [Abstract][Full Text] [Related]
33. Anaphase-promoting complex/cyclosome controls the stability of TPX2 during mitotic exit.
Stewart S; Fang G
Mol Cell Biol; 2005 Dec; 25(23):10516-27. PubMed ID: 16287863
[TBL] [Abstract][Full Text] [Related]
34. [miR-491 inhibits the proliferation, invasion and migration of hepatocellular carcinoma cell via down-regulating TPX2 expression].
Wang J; Liu Z; Dou C; Han S; Li C; Tu K; Yang W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Apr; 32(4):512-7. PubMed ID: 27053618
[TBL] [Abstract][Full Text] [Related]
35. Ashwagandha derived withanone targets TPX2-Aurora A complex: computational and experimental evidence to its anticancer activity.
Grover A; Singh R; Shandilya A; Priyandoko D; Agrawal V; Bisaria VS; Wadhwa R; Kaul SC; Sundar D
PLoS One; 2012; 7(1):e30890. PubMed ID: 22303466
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive Analysis of the Oncogenic Role of Targeting Protein for Xklp2 (TPX2) in Human Malignancies.
Shao T; Jiang X; Bao G; Li C; Guo C
Dis Markers; 2022; 2022():7571066. PubMed ID: 36304254
[TBL] [Abstract][Full Text] [Related]
37. Validation of TPX2 as a potential therapeutic target in pancreatic cancer cells.
Warner SL; Stephens BJ; Nwokenkwo S; Hostetter G; Sugeng A; Hidalgo M; Trent JM; Han H; Von Hoff DD
Clin Cancer Res; 2009 Nov; 15(21):6519-28. PubMed ID: 19861455
[TBL] [Abstract][Full Text] [Related]
38. Integrative analysis confirms TPX2 as a novel biomarker for clinical implication, tumor microenvironment, and immunotherapy response across human solid tumors.
Zhu M; Wang X; Zhang Q; Xie C; Wang T; Shen K; Zhang L; Zhou X
Aging (Albany NY); 2024 Feb; 16(3):2563-2590. PubMed ID: 38315450
[TBL] [Abstract][Full Text] [Related]
39. Glioma pathogenesis-related protein 1 induces prostate cancer cell death through Hsc70-mediated suppression of AURKA and TPX2.
Li L; Yang G; Ren C; Tanimoto R; Hirayama T; Wang J; Hawke D; Kim SM; Lee JS; Goltsov AA; Park S; Ittmann MM; Troncoso P; Thompson TC
Mol Oncol; 2013 Jun; 7(3):484-96. PubMed ID: 23333597
[TBL] [Abstract][Full Text] [Related]
40. TPX2 siRNA regulates growth and invasion of esophageal cancer cells.
Liu HC; Zhang GH; Liu YH; Wang P; Ma JF; Su LS; Li SL; Zhang L; Liu JW
Biomed Pharmacother; 2014 Sep; 68(7):833-9. PubMed ID: 25239289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
